Medisus Pharma

Product Name: Denotec™
Generic Name: Denosumab Injection
Strength: 120 mg/1.7 mL (70 mg/mL)
Dosage Form: Injection
Route of Administration: Subcutaneous Use Only
Pack Size: 1 Vial

Product Overview

Denotec™ (Denosumab Injection 120 mg/1.7 mL) is a monoclonal antibody used in oncology and bone-related disorders. It helps reduce bone complications in patients with cancers that have spread to bones and is also used in the treatment of giant cell tumor of bone.

Indications

• Prevention of skeletal-related events in patients with bone metastases from solid tumors
• Treatment of Giant Cell Tumor of Bone (GCTB)
• Management of bone destruction associated with advanced cancers

Composition

Each vial contains:

• Denosumab: 120 mg in 1.7 mL

Storage

• Store at 2°C to 8°C
• Do not freeze
• Protect from light
• Keep out of reach of children

Key Features

• High-quality oncology injectable
• Ready-to-use formulation
• Reliable support for bone protection therapy
• Manufactured under quality-controlled standards

Manufacturer / Marketer

Marketed by: Hetero Healthcare Limited

Supplied By

Medisus Pharma
Wholesale & Retail Dealer of Life Saving Drugs & Speciality Medicines

Ideal for:

• Hospitals
• Oncology Clinics
• Specialty Pharmacies
• Medical Distributors
• Export Supply